Hepatitis C virus and the immunological response to hepatitis B virus vaccine in dialysis patients: Meta-analysis of clinical studies

Journal of Viral Hepatitis

Volumn 18, Issue 12, 2011, Pages 871-876

  Fabrizi, F ^a   Dixit, V ^b   Martin, P ^b   Messa, P ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

dialysis; hepatitis B virus; hepatitis C virus; meta analysis; vaccine

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B VACCINE;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; EVALUATION; HEMODIALYSIS PATIENT; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNE RESPONSE; META ANALYSIS; PRIORITY JOURNAL; SYSTEMATIC REVIEW; TREATMENT RESPONSE; VACCINATION;

ADOLESCENT; ADULT; AGED; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; RENAL DIALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 81555223023     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2011.01459.x     Document Type: Article

References (37)

1. Fabrizi F, Martin P,. Hepatitis B virus infection in dialysis patients. Am J Nephrol 2000; 20: 1-11. (Pubitemid 30047863)
2. Centers for Disease Control and Prevention. Recommendations for preventing transmission of infections among chronic haemodialysis patients. MMWR Morb Mortal Wkly Rep 2001; 50: 1-43.
3. Finelli L, Miller JT, Tokars JI, Alter MJ, Arduino MJ,. National surveillance of dialysis-associated diseases in the United States, 2002. Semin Dial 2005; 18: 52-61. (Pubitemid 40348277)
4. Navarro J, Teruel J, Mateos M, Ortuno J,. Hepatitis C virus infection decreases the effective antibody response to hepatitis B vaccine in hemodialysis patients. Clin Nephrol 1994; 41: 113-116. (Pubitemid 24057169)
5. Poynard T, Conn HO,. The retrieval of randomised clinical trials in liver diseases from the medical literature: a comparison of Medlars and manual methods. Control Clin Trials 1985; 6: 271-279. (Pubitemid 16173553)
6. DerSimonian R, Laird N,. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188. (Pubitemid 17189972)
7. Petitti DB,. Approaches to heterogeneity in meta-analysis. Stat Med 2001; 20: 3625-3633. (Pubitemid 33114432)
8. Higgins JPT, Thompson SG, Deeks JI, Altman DG,. Measuring inconsistencies in meta-analysis. Br Med J 2003; 327: 557-560.
9. Galbraith RF,. A note on graphical presentation of estimated odds ratios from several clinical trials. Stat Med 1988; 7: 889-894.
10. Klein S, Simes J, Blackburn GL,. Total parenteral nutrition and cancer clinical trial. Cancer 1986; 58: 1378-1386. (Pubitemid 16053158)
11. Navarro J, Teruel J, Mateos M, Marcen R, Ortuno J,. Antibody level after hepatitis B vaccination in hemodialysis patients: influence of hepatitis C virus infection. Am J Nephrol 1996; 16: 95-97. (Pubitemid 26050662)
12. Cheng CH, Huang C, Leu M, Chiang C, Wu M, Lai PC,. Hepatitis B vaccine in hemodialysis patients with hepatitis C viral infection. Vaccine 1997; 15: 1353-1357. (Pubitemid 27397813)
13. Kara I, Yilmaz M, Suner A, Kadiroglu A, Isikoglu B,. The evaluation of immune responses that occur after HBV infection and HBV vaccination in hemodialysis patients. Vaccine 2004; 22: 3963-3967. (Pubitemid 39208759)
14. Weinstein T, Chagnac A, Boaz M, et al. Improved immunogenicity of a novel third-generation recombinant hepatitis B vaccine in patients with end-stage renal disease. Nephron Clin Pract 2004; 97: c67-c72. (Pubitemid 38823879)
15. Liu Y, Kao M, Huang C,. A comparison of responsiveness to hepatitis B vaccination in patients on hemodialysis and peritoneal dialysis. Vaccine 2005; 23: 3957-3960. (Pubitemid 40726189)
16. Sorkhi H, Roushan MR, Al Hashemi G, Dooki M, Bai S,. Response to hepatitis B virus vaccination in haemodialysis patients with and without hepatitis C infection. East Mediterr Health J 2008; 14: 798-803.
17. Bock M, Barros E, Veronese F,. Hepatitis B vaccination in haemodialysis patients: a randomized clinical trial. Nephrology 2009; 14: 267-272.
18. Afsar B, Elsurer R, Eyileten T, Yilmaz M, Caglar K,. Antibody response following hepatitis B vaccination in dialysis patients: does depression and life quality matter? Vaccine 2009; 27: 5865-5869.
19. Fabrizi F, Martin P, Dixit V, Bunnapradist S, Dulai G,. Meta-analysis: the effect of age on immunological response to hepatitis B vaccine in end-stage renal disease. Aliment Pharmacol Ther 2004; 20: 1053-1062. (Pubitemid 39657938)
20. Fernandez E, Betru MA, Gomez R, Montoliu J,. Response to the hepatitis B virus vaccine in haemodialysis patients: influence of malnutrition and its importance as a risk factor for morbidity and mortality. Nephrol Dial Transplant 1996; 11: 1559-1563. (Pubitemid 26252723)
21. Ahuja TS, Kumar S, Mansoury H, Rodriguez H, Kuo YF,. Hepatitis B vaccination in human immunodeficiency virus-infected adults receiving haemodialysis. Kidney Int 2005; 67: 1136-1141. (Pubitemid 41623340)
22. Sennesael J, van der Niepen P, Verbeelen DL,. Treatment with recombinant human erythropoietin increases antibody titers after hepatitis B vaccination in dialysis patients. Kidney Int 1991; 40: 121-128.
23. Pol S, Legendre C, Mattlinger B, Berthelot P, Krein H,. Genetic basis of nonresponse to hepatitis B vaccine in hemodialysis patients. J Hepatol 1990; 11: 385-387.
24. Jibani MM, Heptonstall J, Walker AM, Bloodworth LO, Howard AJ,. Hepatitis B immunization in UK renal units: failure to put policy into practice. Nephrol Dial Transplant 1994; 9: 1765-1768.
25. Alavian SM, Tabatabaei S,. The effect of diabetes mellitus on immunological response to hepatitis B virus vaccine in individuals with chronic kidney disease: a meta-analysis of clinical trials. Vaccine 2010; 28: 3773-3777.
26. Kamel M, Manialawi ME, Miller FD,. Recombinant hepatitis B vaccine immunogenicity in presence of hepatitis C virus seropositivity. Lancet 1994; 343: 552 [letter]. (Pubitemid 24062316)
27. Lee S, Chan C, Yu M, Lu R, Chang F, Lo K,. Hepatitis B vaccination in patients with chronic hepatitis C. J Med Virol 1999; 59: 463-468. (Pubitemid 29523144)
28. Hachem C, Kramer J, Kanwal F, El-Serag H,. Hepatitis vaccination in patients with hepatitis C: practice and validation of codes at a large veterans administration medical centre. Aliment Pharmacol Ther 2008; 28: 1078-1087.
29. Hernandez B, Hasson N, Cheung R,. Hepatitis C performance measure on hepatitis A and B vaccination: missed opportunities. Am J Gastroenterol 2009; 104: 1961-1967.
30. Koeffe EB,. Hepatitis A and B superimposed on chronic liver disease: vaccine-preventable diseases. Trans Am Clin Climatol Assoc 2006; 117: 227-238.
31. Lacson E, Teng M, Ong J, Vienneau L, Ofsthun N, Lazarus J,. Antibody response to Engerix-B and Recombivax-HB hepatitis B vaccination in end stage renal disease. Hemodial Int 2005; 9: 367-375. (Pubitemid 41614648)
32. Moher D, Pham B, Jones A, et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 1998; 352: 609-613. (Pubitemid 28380142)
33. Fabrizi F, Di Filippo S, Marcelli D, et al. Recombinant hepatitis B vaccine use in chronic hemodialysis patients. Nephron 1996; 72: 536-543.
34. Waite M, Thomson L, Goldstein M,. Successful vaccination with intradermal hepatitis B vaccine in hemodialysis patients previously nonresponsive to intramuscular hepatitis B vaccine. J Am Soc Nephrol 1995; 5: 1930-1934.
35. Marangi A, Giordano R, Montanaro A, de Padova F, Schiavone MG, Basile C,. Hepatitis B virus infection in chronic uraemia: long-term follow-up of a two-step integrated protocol of vaccination. Am J Kidney Dis 1994; 23: 537-542. (Pubitemid 24109115)
36. DaRoza G, Loewen A, Durdjev O, et al. Stage of chronic kidney disease predicts seroconversion after hepatitis B immunization: earlier is better. Am J Kidney Dis 2003; 42: 1184-1192. (Pubitemid 37486762)
37. Rangel M, Coronado V, Euler G, Strikas R, for the Advisory Committee on Immunization Practices and the American Academy of Pediatrics. Vaccine recommendations for patients on chronic dialysis. Semin Dial 2002; 13: 101-107.